Akanda (AKAN) vs InMed Pharmaceuticals (INM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
InMed Pharmaceuticals is the larger company by market cap ($7.3 million vs $4.7 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKAN | INM |
|---|---|---|
| Share price | $1.78 | $1.33 |
| Market cap | $4.70M | $7.31M |
| 1-day change | -7.77% | 0.00% |
| EPS (TTM) | $-14,935.32 | $-2.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $78.90 | $2.40 |
| 52-week low | $1.73 | $0.575 |
| Distance from 52-week high | -97.74% | -44.58% |
| Average volume | 1.35M | 914.23K |
| Shares outstanding | 2.39M | 5.49M |
| Employees | — | 6 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Akanda
AKAN stock →Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers.
Healthcare · Drug Manufacturers - Specialty & Generic
About InMed Pharmaceuticals
INM stock →InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
Healthcare · Drug Manufacturers - Specialty & Generic · 6 employees
AKAN vs INM FAQ
Which is bigger, Akanda or InMed Pharmaceuticals?
InMed Pharmaceuticals (INM) is larger, with a market capitalization of $7.31M compared with $4.70M for Akanda (AKAN).
Are Akanda and InMed Pharmaceuticals in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.